Endocrine Abstracts

Introduction: VEGFA is considered the main angiogenic factor in adipose tissue. It is believed that a low angiogenic capacity may decrease the adipogenic potential and consequently promotes adipocyte hypertrophy, which in turn, is closely related to insulin resistance (IR). Oestradiol (E2) is a regulator of the VEGFA gene and a protector against obesity. However nothing is known about the E2 effects on VEGF adipocyte production, and its consequence for ce...

Diabetes mellitus (DM) is an important cause of morbidity and mortality on a global scale. The pathophysiology of DM involves insulin resistance, even in insulin-treated type 1 DM, which in turn is related to the amount of glucose transporter GLUT4 (Slc2a4 gene). Estrogen activity can be mediated by two distinct receptors (ESR1 and ESR2) and may involve genomic and non-genomic mechanisms. Estrogen has been described as involved in glycemic homeostasis, but the related...

According to the world Health Organization, about 422 million people worldwide have diabetes mellitus (DM), and this number is growing rapidly. DM, mainly type 2, is associated with insulin resistance, which involves reduced expression of glucose transporter GLUT4 (Slc2a4 gene). It is known that estrogen can modulate glycemic homeostasis and seems to involve changes in the Slc2a4/GLUT4 expression. There has been an increased interest in plant-derived phytoest...

Introduction: GLUT4 protein is the most important isoform of glucose transporters in skeletal muscle. Reduction in its content and/or translocation is related to insulin resistance and type 2 diabetes mellitus. In skeletal muscle cells there is also an ATP-sensitive potassium (KATP) channel with two subunits, sulfonylurea receptor type 2A, ABCC9 (SUR2A) and KIR6.2 (KCNJ11). In pancreatic B cells, this channel triggers insulin secretion in response to the rise in glucose levels...